AstraZeneca could be Britain’s next loss:
AstraZeneca’s deal talks with US-headquartered Bristol Myers Squibb, which Semafor confirms remain active ...
semafor.com/article/08/04/2026/astrazeneca-could-be-britains-next-loss
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
Similar to This
Previous
China's Speed in Clinical Trials Draws Drugmakers Roche, AstraZeneca, Novartis: More pharmaceutical companies are taking early-stage research to the country ...
bloomberg.com/news/features/2026-10-29/china-s-speed-in-clinical-trials-draws-drugmakers-roche-astrazeneca-novartis
Paid articlePaywall
AstraZeneca increases profit thanks to cancer drugs, plans major savings program: AstraZeneca increased net profit by 23 percent in the third quarter thanks to ...
de.euronews.com/2026/10/30/astrazeneca-steigert-gewinn-dank-krebsmedikamenten-plant-grosses-sparprogramm
AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says
dlvr.it/TW5w9d
Lawsuit against Bristol Myers over delayed cancer drug is revived: A U.S. federal appeals court said a judge erred in dismissing a $6.7 billion lawsuit accusing ...
reuters.com/legal/government/lawsuit-against-bristol-myers-over-delayed-cancer-drug-is-revived-2026-08-13/
Bristol Myers Squibb is building a $2.3 billion drug manufacturing campus in Houston
qz.com/bristol-myers-squibb-manufacturing-campus-houston-texas-081026
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says: There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a ...
reuters.com/world/no-discussions-over-astrazeneca-bristol-myers-deal-senior-source-says-2026-08-05/
AstraZeneca and BMS: Why the biggest deal in history is surprising: The British pharmaceutical company AstraZeneca and its US competitor Bristol Myers Squibb are ...
wiwo.de/finanzen/boerse/astrazeneca-und-bms-deshalb-kommtgroesste-deal-der-geschichte-ueberraschend/100244645.html
OpinionPharma merger of AstraZeneca and BMS: Not a dream match: The stock market is reacting with concern to the rumors of a merger between AstraZeneca and BMS ...
faz.net/aktuell/wirtschaft/pharma-fusion-von-astra-zeneca-und-bms-keine-traum-hochzeit-201090912.html
Struggling to make sense of AstraZeneca-BMS: All about oncology? A cardio workout? Patent-cliff avoidance? American dreaming?
ft.com/content/eddbdc29-5206-4c79-9ea7-f1a06ff040f1
Paid articlePaywall
Trump’s bully boy tactics bringing Big Pharma to heel: Determination to cut prices for medicines in US may yet pile pressure on creaking European health budgets
irishtimes.com/business/2025/10/14/trump-really-is-bringing-big-pharma-to-heel/
AstraZeneca’s listing rejig spells long-term danger for London: It’s not skipping off entirely to New York, but pharma giant sets a worrying precedent for UK ...
theguardian.com/business/nils-pratley-on-finance/2025/sep/29/astrazenecas-listing-rejig-spells-long-term-danger-for-london
Exclusive: AstraZeneca pauses $270 million investment in Britain: Britain's biggest company AstraZeneca has paused a planned 200 million pound ($271 ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-pauses-270-million-investment-britain-2025-09-12/
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time: Little-known provisions lobbied by industry will cost Medicare billions in missed ...
wsj.com/health/pharma/trump-tax-spending-bill-drug-prices-medicare-5465f4e2
Astrazeneca chief ‘wants to shift London listing to US’: The boss of Astrazeneca has reportedly voiced his desire to transfer the pharma giant's listing to the ...
cityam.com/astrazeneca-chief-wants-to-shift-listing-to-us/
Next